Description
Adipotide – Targeted Fat Reduction Research Peptide
Adipotide 5 mg (FTPP – Fat-Targeted Peptide) is a synthetic peptide engineered to induce apoptosis of adipose tissue blood vessels, leading to localized fat loss through vascular targeting. It represents a novel research approach to non-hormonal fat reduction, focusing on disrupting the blood supply to adipocytes rather than altering metabolism or appetite.
Originally developed for metabolic and obesity-related studies, Adipotide has shown promising results in reducing body fat, improving insulin sensitivity, and enhancing metabolic efficiency in preclinical research models.
Key Features & Research Applications
🔥 Targeted Fat Reduction:
Acts by cutting off blood flow to fat cells, causing apoptosis of adipose tissue vasculature.
💉 Non-Hormonal Mechanism:
Does not alter hormonal balance; works through vascular targeting rather than metabolic modulation.
🧬 Improved Metabolic Function:
Research shows potential improvements in insulin sensitivity and glucose regulation.
💪 Obesity & Metabolic Studies:
Valuable for investigating obesity mechanisms, fat metabolism, and body composition regulation.
❤️ Potential Cardiometabolic Benefits:
Studied for reducing visceral fat and improving lipid and insulin profiles in obese research models.
Product Details
-
Name: Adipotide (FTPP – Fat-Targeted Peptide)
-
Form: Lyophilized powder
-
Sequence: CKGGRAKDC-GG-D(KLAKLAK)₂
-
Molecular Formula: C₇₅H₁₃₉N₂₇O₂₄S₂
-
Molecular Weight: 1715.07 g/mol
-
Purity: ≥ 98% (HPLC verified)
-
Dosage Strength: 5 mg per vial
-
Appearance: White to off-white lyophilized powder
-
Storage: Store in a cool, dry environment; refrigerate (35.6–46.4°F) after reconstitution.
-
Packaging: Sterile, sealed vial for laboratory use.
-
Verification: Third-party laboratory tested for purity and identity.
